Rochester Medical Corporation's CEO Discusses Q3 2012 Results - Earnings Call Transcript
Rochester Medical Corporation (ROCM)
Q3 2012 Earnings Call
July 27, 2012 11:00 a.m. ET
Anthony J. Conway – President & CEO
Bruce Jackson Tyson Bauer Beth Lilly Larry Haimovitch Tyson Bauer Matt Lee Michael Boulgaris Presentation
Previous Statements by ROCM
» Rochester Medical Corporation's CEO Discusses Q2 2012 Results - Earnings Call Transcript
» Rochester Medical CEO Discusses F1Q 2012 Results - Earnings Call Transcript
» Rochester Medical's CEO Discusses F4Q 2011 Results - Earnings Call Transcript
» Rochester Medical Discusses Q2 2011 Results -- Earnings Call Transcript
Good morning. Thank you for joining Rochester Medical ’s third quarter conference call. I ’m Jim Conway, the company ’s President and CEO. And with me is David Jonas, Rochester Medical ’s Chief Financial Officer. First, I will provide a brief high level review of our third quarter and Dave will then provide you with more details on our financial results, and then I ’ll give a quick update on a few items and summarize, and we will take your questions. Before starting, let me remind you that we will be making some forward-looking statements today, and I would refer you to the Safe Harbor statement found in today ’s press release and also to the Risk Factors section in the company ’s Annual Report on Form 10-K for the year ended September 30, 2011. These statements further clarify the risks and uncertainties that are associated with the forward-looking statements. Okay. In total revenues grew 7% on a reported basis and 10% on a constant currency basis to a total of $15.3 million. Our goal of direct sales business had 9% constant currency growth with the U.S. direct sales business leading the way with a robust 34% increase, paced by good strength in our Home Care market.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV